These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 16822222)
1. The performance of nanocarriers for transmucosal drug delivery. Csaba N; Garcia-Fuentes M; Alonso MJ Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222 [TBL] [Abstract][Full Text] [Related]
2. Nanoparticles as carriers for nasal vaccine delivery. Köping-Höggård M; Sánchez A; Alonso MJ Expert Rev Vaccines; 2005 Apr; 4(2):185-96. PubMed ID: 15889992 [TBL] [Abstract][Full Text] [Related]
3. Nanocarriers for oral drug delivery. Zhang L; Wang S; Zhang M; Sun J J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127 [TBL] [Abstract][Full Text] [Related]
4. Nanomedicines for overcoming biological barriers. Alonso MJ Biomed Pharmacother; 2004 Apr; 58(3):168-72. PubMed ID: 15082339 [TBL] [Abstract][Full Text] [Related]
5. Cell-penetrating peptides for drug delivery across membrane barriers. Foged C; Nielsen HM Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931 [TBL] [Abstract][Full Text] [Related]
9. Chitosan and its salts for mucosal and transmucosal delivery. Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C Expert Opin Drug Deliv; 2009 Sep; 6(9):923-39. PubMed ID: 19637983 [TBL] [Abstract][Full Text] [Related]
11. The forthcoming applications of gold nanoparticles in drug and gene delivery systems. Pissuwan D; Niidome T; Cortie MB J Control Release; 2011 Jan; 149(1):65-71. PubMed ID: 20004222 [TBL] [Abstract][Full Text] [Related]
12. Fabrication of solid nanoparticles for drug delivery. Arayne MS; Sultana N; Noor-Us-Sabah Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113 [TBL] [Abstract][Full Text] [Related]
13. [Recent advances in liposomes and nanoparticles as drug carriers for drug delivery]. Liu Y; Lü WL; Zhang Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):583-9. PubMed ID: 16995319 [TBL] [Abstract][Full Text] [Related]
14. A review of stimuli-responsive nanocarriers for drug and gene delivery. Ganta S; Devalapally H; Shahiwala A; Amiji M J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822 [TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for nasal vaccination. Csaba N; Garcia-Fuentes M; Alonso MJ Adv Drug Deliv Rev; 2009 Feb; 61(2):140-57. PubMed ID: 19121350 [TBL] [Abstract][Full Text] [Related]
16. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective. Hunter AC; Elsom J; Wibroe PP; Moghimi SM Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372 [TBL] [Abstract][Full Text] [Related]
17. Drug delivery from ordered mesoporous matrices. Manzano M; Colilla M; Vallet-Regí M Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412 [TBL] [Abstract][Full Text] [Related]
18. Dendrimers as versatile platform in drug delivery applications. Svenson S Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707 [TBL] [Abstract][Full Text] [Related]
19. Anticancer drug delivery with nanoparticles. Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748 [TBL] [Abstract][Full Text] [Related]
20. Recent advances and future directions in amphiphilic cyclodextrin nanoparticles. Bilensoy E; Hincal AA Expert Opin Drug Deliv; 2009 Nov; 6(11):1161-73. PubMed ID: 19705965 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]